Selective cannabinoid - 1 receptor blockade significantly benefits fatty acid and triglyceride 1 metabolism in weight - stable nonhuman primates 2


34 The goal of this study was to determine whether administration of the CB1-cannabinoid receptor 35 antagonist, rimonabant, would alter fatty acid flux in non-human primates. Five adult baboons (Papio 36 Sp), aged 12.1 ± 4.7y (body weight: 31.9 ± 2.1 kg) underwent repeated metabolic tests to determine fatty 37 acid and TG flux before and after 7 wks of… (More)


1 Figure or Table

Slides referencing similar topics